Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare Conference

BURLINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. FLXN announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Needham 20^th Annual Healthcare Conference. The virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Thursday, April 15, 2021.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics FLXN is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com